Skip to content

Tectonic Therapeutics TECX Market capitalization

Market capitalization at other companies

ALN
Alnylam PharmaceuticalsALNY
$43.88B+25.6%
Septerna, Inc. logo
Septerna, Inc.SEPN
$1.08B+319%
Regenxbio logo
RegenxbioRGNX
$432.52M+20.8%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
$636.46M-11.9%
Opko Health logo
Opko HealthOPK
$865.34M-22.4%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$379.6M+14.8%

Other financials

Income statement

See full
Operating income-$27.3M-49.2%
Net income-$25.2M-58.7%
EPS (diluted)-$1.34-44.1%

Balance sheet

See full
Cash & equivalents$236.9M-22.8%
Total debt$4.9M+86.1%
Total equity$230.4M-23.5%
Total assets$246.6M-21.7%

Cash flow

See full
Operating cash flow-$18.4M-40.7%
CapEx$19.0K-29.6%
Free cash flow-$18.4M-40.6%

Valuation

See full
Enterprise value$353.51M+438%

Returns & leverage

See full
Return on equity-31.4%
Debt / equity0.0×
Current ratio18.5×-4.4×

Where this comes from

Computed from the period-end share price: $580.39M.

The official record: Tectonic Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tectonic Therapeutics's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tectonic Therapeutics's market capitalization?
Tectonic Therapeutics (TECX) reported market capitalization of $580.39M in Q1 2026.
How has Tectonic Therapeutics's market capitalization changed year-over-year?
Tectonic Therapeutics's market capitalization increased by 75.6% year-over-year, from $330.52M to $580.39M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.